AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination
来源：Reuters发布于 2026-09-29
HUTCHMED (China) said on Tuesday Anglo-Swedish drugmaker AstraZeneca had filed an application with the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination in pat...
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。